Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 14,482 |
|
|||||
| News | - | ||||||
| Day High | 2.56 | Low High |
|||||
| Day Low | 2.3901 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Minerva Neurosciences Inc | NERV | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -0.81% | 2.45 | 17:24:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.49 | 2.3901 | 2.56 | 2.50 | 2.47 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 137 | 14,482 | $ 2.47 | $ 35,786 | - | 2.2591 - 13.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:24:54 | formt | 290 | $ 2.45 | USD |
Minerva Neurosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.48M | 6.99M | - | 0 | -30.01M | -4.29 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Minerva Neurosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NERV Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.47 | 2.80 | 2.2864 | 2.48 | 28,611 | -0.02 | -0.81% |
| 1 Month | 2.73 | 2.80 | 2.2864 | 2.54 | 23,667 | -0.28 | -10.26% |
| 3 Months | 7.70 | 13.49 | 2.2864 | 4.58 | 128,206 | -5.25 | -68.18% |
| 6 Months | 5.56 | 13.49 | 2.2864 | 4.89 | 73,304 | -3.11 | -55.94% |
| 1 Year | 2.70 | 13.49 | 2.2591 | 8.81 | 315,318 | -0.25 | -9.26% |
| 3 Years | 2.53 | 15.27 | 0.327884 | 6.76 | 881,884 | -0.08 | -3.16% |
| 5 Years | 7.11 | 15.27 | 0.327884 | 5.88 | 888,893 | -4.66 | -65.54% |
Minerva Neurosciences Description
| Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. Targeted disorders include schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease. |
